Completed NA NCT00002066
Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection
Sponsor: Immunobiology Research Institute
Conditions
HIV Infections
Interventions
Thymopentin
Updated 5 times since 2017 Last updated: Jun 23, 2005
Listed as NCT00002066, this NA trial focuses on HIV Infections and remains completed. Sponsored by Immunobiology Research Institute, it has been updated 5 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
-
Jan 2017 — Jun 2018 [monthly]
Completed NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Immunobiology Research Institute
Data source: NIH AIDS Clinical Trials Information Service
For direct contact, visit the study record on ClinicalTrials.gov .